Blackspear, leveraging a proprietary intelligence platform, serves as a research-driven advisory engine for operators, boards of directors, and investors. We concentrate on understanding how major structural forces shape strategy, margins, capital allocation, competitive positioning, and governance.
Our insights are guided by over 60 years of aggregate experience and enriched by proven, high-stakes judgment, operational experience, and disciplined governance. Key areas of focus in our research include Blackspear's Four Freight Trains:
1. AI & Automation: the shift from software as a tool to intelligence as infrastructure.
2. Energy, Power & Industrial Electrification: the physical constraints impacting AI, reshoring, grid demand, and industrial development.
3. Monetary Regime Change & Geopolitical Fragmentation: the effects of fractured trust, capital flows, trade relationships, and national security alignments.
4. The Healthspan Economy: combining metabolic health, diagnostics, devices, data, and incentives to develop a new healthspan stack.

Blackspear develops board- and investor-ready strategic growth plans for companies ranging from emerging businesses to large multinational corporations. Our work integrates strategy, market analysis, detailed financial modeling, capital requirements and executive-level presentations into a clear roadmap for growth.
Blackspear helps clients develop and execute capital formation strategies aligned with their objectives and stage of development. We support financing preparation, investor materials, capital structure analysis, investor outreach and transaction execution across select debt and equity opportunities.
Blackspear advises clients through the full M&A process, from strategic assessment and target identification through valuation, negotiation, due diligence and closing. We bring senior-level transaction experience and disciplined execution to acquisitions, divestitures and other strategic alternatives.
Blackspear selectively provides independent board representation to companies that can benefit from experienced judgment in strategy, capital allocation, M&A and governance. We bring an owner-oriented perspective, constructive challenge and practical operating and transaction experience to the boardroom.
Kurt M. Roth is the founder and managing member of Blackspear, LLC, a firm providing proprietary, research-driven corporate strategy and investment advisory services. With 30 years of experience in corporate development, strategy, investment banking, capital allocation, and governance across public companies, private equity-backed businesses, and founder- or family-owned enterprises, Kurt has demonstrated thoughtful leadership and exceptional outcomes throughout his career.
From 2022 to 2024, he served as a Partner and Head of Healthcare at Compass Diversified (NYSE: CODI), a permanent capital vehicle focused on acquiring and building middle-market businesses. Before this, from 2015 to 2022, Kurt held the position of Senior Vice President of Corporate Development and Strategy at Sotera Health (NASDAQGS: SHC), a global leader in mission-critical sterilization and lab testing services, where he led M&A, strategic planning, and capital allocation across a complex, regulated operating platform. Before that, he was an investment banker at Robert W. Baird & Co. from 2007 to 2015, where he earned the title of Partner and Managing Director before being recruited to Sotera Health. Kurt began his investment banking career in the M&A Group at Montgomery Securities in San Francisco, CA. He holds a BA from the University of California, Berkeley, and he and his wife reside in downtown Chicago, IL.
Select Transactional Experience
HEALTHCARE FOCUS: Nelson Laboratories (US) — Buy-side: Largest U.S. provider of lifecycle microbiology testing. Toxikon Europe (Belgium) — Buy-side: Leading global extractables & leachables biopharmaceutical testing lab. Nordion Medical Isotopes (Canada) — Sell-side: Leading medical isotope platform. Iotron Industries (US & Canada) — Buy-side: E-beam sterilization platform; geographic and technology diversification for Sterigenics. Regulatory Compliance Associates (US) — Buy-side: Regulatory advisory platform; broadened Nelson’s compliance offerings. Gibraltar Laboratories (US) — Buy-side: Biopharma-focused analytical lab in the Northeast; proximity to Nelson’s key customers. BioScience Laboratories (US) — Buy-side: Analytical lab services for pharma, medical device, and consumer hygiene; expanded Nelson’s service offering. Reviss Services (UK) — Buy-side: Strategic add-on for Nordion; supplier of gamma radiation technology and associated services. DNA Diagnostic Center (US) — Sell-side: Acquired by GHO Capital from WindRose Health Investors. i-Trax (US) — Sell-side: Acquired by Meridian Occupational Healthcare.
CONSUMER, INDUSTRIAL, & BUSINESS SERVICES: Bass Pro Shops (US) — Sell-side: Acquisition by J.W. Childs; growth and store expansion. Bushnell (US) — Sell-side: Acquisition by ATK; strategic sporting optics combination. CorePower Yoga (US) — Sell-side: Buyout with Catterton Partners; growth and franchising expansion. Beachbody (US) — Sell-side: Acquisition by LNK Partners; health & wellness platform scale-up. Founders Brewing Company (US) — Sell-side: Recapitalization with Mahou San Miguel (Spain). Battenfeld Technologies (US) — Sell-side: Acquired by Smith & Wesson Brands. Feradyne Outdoors (US) — Sell-side: Acquired by Snow Phipps. Fitness Connection (US) — Sell-side: Acquired by LNK Partners. Wisconsin Specialty Protein (US) — Sell-side: Acquired by Omega Protein. Plano Molding (US) — Buy-side: Acquired by Ontario Teachers’ Pension Plan. Crosman (US) — Sell-side: Acquired by Wellspring Capital Management. Ames True Temper (US) — Sell-side: Acquired by Griffon Corporation. Liberty Safe (US) — Sell-side: Acquired by Compass Diversified. Zenith Administrators (US) — Buy-side: Acquired by Aspen Partners and Caltius. Jerdon Products/Newell Rubbermaid (US) — Sell-side: Acquired by Focus Products. Pelstar (US) — Sell-side: Acquired by Newell Rubbermaid. Rogue Wave Software (US) — Sell-side: Acquired by Quovadx. Fender Guitar (US) — Sell-side: Acquired by Weston Presidio.
CAPITAL MARKETS/IPOs: Sotera Health Company (US) — IPO & follow-on offerings; role: SVP, Corporate Development. Fox Racing Shox (Fox Factory) (US) — IPO (lead left) and follow-on (bookrunner); Compass Diversified portfolio company. MasterCraft (US) — IPO (lead left bookrunner); leading sport boat manufacturer. Planet Fitness (US) — IPO; TSG Consumer Partners portfolio company. Freshpet (US) — IPO and follow-on offerings; MidOcean Partners portfolio company. BRP (Bombardier Recreational Products) (Canada) — IPO and follow-on offerings; Bain Capital portfolio company.
Contact us for more information.
Copyright © 2026 Blackspear, LLC - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.